<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MELOXICAM</span><br/>(mel-ox'-i-cam)<br/><span class="topboxtradename">Mobic<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent (cns)</span>; <span class="classification">analgesic</span>; <span class="classification">nonsteroidal anti-inflammatory drug (nsaid)</span><br/><b>Prototype: </b>Ibuprofen<br/><b>Pregnancy Category: </b>C (first and second trimesters); D (third trimester)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>7.5 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits anti-inflammatory, analgesic, and antipyretic activities. The
         mechanism of action, like other NSAIDs, may be related to prostaglandin synthetase (cyclooxygenase) inhibition.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Exhibits antiinflammatory, analgesic, and antipyretic actions.</p>
<h1><a name="uses">Uses</a></h1>
<p>Relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to meloxicam; rhinitis, urticaria/angioedema, asthma; allergic reactions to aspirin or other antiinflammatory
         agents; NSAID hypersensitivity, severe renal or hepatic disease; salicylate hypersensitivity, pregnancy [(category C) first
         and second trimester, (category D) third trimester)], lactation; bleeding.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>
<i>Helicobacter pylori</i> infections; history of coagulation defects, liver dysfunction, gastrointestinal disease or ulceration, anemia, anticoagulant
         therapy; asthma; bone marrow suppression; corticosteroid therapy, dehydration, edema, older adults; females of childbearing
         age; GI bleeding, GI diseases, GI perforation; heart failure; hepatic disease, hypertension, hypovolemia, immunosuppression;
         jaundice, lactase deficiency, advanced renal dysfunction; hypertension or cardiac conditions aggravated by fluid retention
         and edema.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Osteoarthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 7.515 mg once daily<br/><br/><span class="indicationtitle">Rheumatoid Arthritis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 15 mg once daily<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Do not exceed the maximum recommended daily dose of 15 mg.</li>
<li>Use the lowest effective dose for the shortest duration to minimize risk of serious adverse effects.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Edema, fall, flu-like syndrome, pain. <span class="typehead">GI:</span> Abdominal pain, diarrhea, dyspepsia, flatulence, nausea, constipation, <span class="speceff-life">ulceration, GI bleed</span>. <span class="typehead">Hematologic:</span> Anemia. <span class="typehead">Musculoskeletal:</span> Arthralgia. <span class="typehead">CNS:</span> Dizziness, headache, insomnia. <span class="typehead">Respiratory:</span> Pharyngitis, upper respiratory tract infection, cough. <span class="typehead">Skin:</span> Rash, pruritus. <span class="typehead">Urogenital:</span> Micturition frequency, urinary tract infection. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May decrease effectiveness of <span class="classification">ace inhibitors</span>, <span class="classification">diuretics</span>; <b>aspirin</b> may increase risk of GI bleed; may increase <b>lithium</b> levels and toxicity; <b>warfarin</b> may increase risk of bleeding. <span class="typehead">Herbal:</span>
<b>Feverfew,</b>
<b>garlic,</b>
<b>ginger,</b>
<b>ginkgo</b> may increase bleeding potential. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 89% bioavailable. <span class="typehead"> Peak:</span> 45 h. <span class="typehead">Distribution:</span> &gt;99% protein bound, distributes into synovial fluid. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP2C9. <span class="typehead">Elimination:</span> Equally eliminated in urine and feces. <span class="typehead">Half-Life:</span> 1520 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for and immediately report S&amp;S of GI ulceration or bleeding, including black, tarry stool, abdominal or stomach pain;
            hepatotoxicity, including fatigue, lethargy, pruritus, jaundice, flu-like symptoms; skin rash; weight gain and edema.
         </li>
<li>Withhold drug and notify physician if hepatotoxicity or GI bleeding is suspected.</li>
<li>Monitor carefully patients with a history of CHF, HTN, or edema for fluid retention.</li>
<li>Monitor diabetics using sulfonylureas for hypoglycemia.</li>
<li>Lab tests: Hgb &amp; Hct, CBC with differential, liver function tests, serum electrolytes, BUN, and creatinine within 3 mo of
            initiating therapy and every 612 mo thereafter; with high-risk patients (e.g., &gt;60 y, history of peptic ulcer disease,
            prolonged or high-dose NSAID therapy, concurrent use of corticosteroids or anticoagulants) monitor within first 34 wk
            and every 36 mo thereafter.
         </li>
<li>Coadministered drugs: With warfarin, closely monitor INR when meloxicam is initiated or dose changed; monitor for lithium
            toxicity, especially during addition, withdrawal, or change in dose of meloxicam.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report any of the following to the physician immediately: nausea, black tarry stool, abdominal or stomach pain, unexplained
            fatigue or lethargy, itching, jaundice, flu-like symptoms, skin rash, weight gain, or edema.
         </li>
<li>Minimize alcohol intake and use of tobacco. Discontinue drug if hepatotoxicity or GI bleeding is suspected. Note that GI bleeding
            may occur without forewarning and is more likely in older adults, in those with a history of ulcers or GI bleeding, and with
            alcohol consumption and cigarette smoking.
         </li>
<li>Do not take aspirin or other NSAIDs while on this medication.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>